Dendritic cell vaccination for glioblastoma multiforme patients: has a new milestone been reached?
/in Dendritic Cells, Glioblastoma, International Publications, IOZK Aktuelles, IOZK VeröffentlichungenThe Viral Knock: Ameliorating Cancer Treatment with Oncolytic Newcastle Disease Virus
/in International Publications, Newcastle Disease VirusEfficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors
/in Breast Cancer, Dendritic Cells, International PublicationsRecent oncolytic virotherapy clinical trials outline a roadmap for the treatment of high-grade glioma
/in Brain Tumors in Children, Glioblastoma, International Publications, Newcastle Disease VirusPotential of Personalized Dendritic Cell-Based Immunohybridoma Vaccines to Treat Prostate Cancer
/in Dendritic Cells, International Publications, Prostate CancerA review of the clinical experience with CMN-001, a tumor RNA loaded dendritic cell immunotherapy for the treatment of metastatic renal cell carcinoma
/in Dendritic Cells, Hypernephroma, International PublicationsThe Application of Evidence-Based Medicine in Individualized Medicine
/in International Publications, IOZK VeröffentlichungenAutologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines
/in Dendritic Cells, Glioblastoma, International Publications, Malignant MelanomaCombination immunotherapy of glioblastoma with dendritic cell cancer vaccines, anti-PD-1 and poly I:C
/in Dendritic Cells, Glioblastoma, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer